Onvansertib (NMS-P937), 1g

Onvansertib (NMS-P937), 1g

SGC-CBP30, 10mg

SGC-CBP30, 10mg

Onvansertib (NMS-P937), 10mM/1mL

2.156,28 RON
SKU
SKM_S7255_10mM/1mL

Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1)inhibitor with IC50of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosisin cancer cell lines and inhibits tumor growth. Phase 1.

Mai multe informatii
Price 1.812,00 RON (preturile sunt fara TVA)
Description

Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1)inhibitor with IC50of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosisin cancer cell lines and inhibits tumor growth. Phase 1.